Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$1.27
-2.67%
Mkt Cap $126.07M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+766.1%
Consensus $11.00 vs current $1.27
NASDAQ·Healthcare·Biotechnology
$1.27
-2.67%
Mkt Cap $126.07M
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+766.1%
Consensus $11.00 vs current $1.27